Ex-Jazz Saks elected to Depomed board
This article was originally published in Scrip
Executive Summary
Speciality pharma company Depomed has appointed Jazz Pharmaceuticals' former co-founder Dr Samuel Saks to the company's board of directors. Dr Saks served as Jazz's CEO from 2003-2009.